Citigroup’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145M Buy
1,848,092
+510,181
+38% +$41.2M 0.05% 345
2026
Q1
$116M Buy
1,337,911
+54,444
+4% +$5.22M 0.05% 359
2025
Q4
$123M Sell
1,283,467
-335,758
-21% -$32.6M 0.05% 308
2025
Q3
$154M Sell
1,619,225
-304,649
-16% -$28M 0.07% 279
2025
Q2
$168M Buy
1,923,874
+118,182
+7% +$10M 0.08% 231
2025
Q1
$162M Buy
1,805,692
+676,883
+60% +$60.6M 0.08% 221
2024
Q4
$90.2M Sell
1,128,809
-163,730
-13% -$14.2M 0.05% 306
2024
Q3
$116M Sell
1,292,539
-55,811
-4% -$4.7M 0.07% 251
2024
Q2
$106M Buy
1,348,350
+97,419
+8% +$7.99M 0.07% 261
2024
Q1
$109M Buy
1,250,931
+101,354
+9% +$8.65M 0.07% 252
2023
Q4
$94.7M Sell
1,149,577
-131,126
-10% -$9.99M 0.07% 266
2023
Q3
$100M Sell
1,280,703
-24,839
-2% -$2.08M 0.08% 234
2023
Q2
$115M Sell
1,305,542
-368,556
-22% -$31.7M 0.08% 199
2023
Q1
$135M Sell
1,674,098
-153,892
-8% -$12.5M 0.09% 169
2022
Q4
$142M Sell
1,827,990
-50,019
-3% -$4.05M 0.11% 161
2022
Q3
$152M Buy
1,878,009
+183,393
+11% +$16.5M 0.11% 140
2022
Q2
$152M Sell
1,694,616
-149,414
-8% -$15.1M 0.11% 146
2022
Q1
$205M Sell
1,844,030
-18,959
-1% -$2M 0.12% 142
2021
Q4
$193M Sell
1,862,989
-435,933
-19% -$50.5M 0.1% 178
2021
Q3
$288M Sell
2,298,922
-187,145
-8% -$24.2M 0.17% 103
2021
Q2
$309M Buy
2,486,067
+63,652
+3% +$7.99M 0.19% 98
2021
Q1
$286M Buy
2,422,415
+463,692
+24% +$54.3M 0.19% 101
2020
Q4
$229M Sell
1,958,723
-115,559
-6% -$12.7M 0.14% 130
2020
Q3
$216M Buy
2,074,282
+456,572
+28% +$45.9M 0.14% 113
2020
Q2
$148M Buy
1,617,710
+363,182
+29% +$34.8M 0.12% 149
2020
Q1
$113M Sell
1,254,528
-208,058
-14% -$22.1M 0.1% 162
2019
Q4
$166M Buy
1,462,586
+215,567
+17% +$23.7M 0.12% 152
2019
Q3
$135M Sell
1,247,019
-781,076
-39% -$81.5M 0.11% 174
2019
Q2
$198M Buy
2,028,095
+128,883
+7% +$11.8M 0.16% 109
2019
Q1
$173M Buy
1,899,212
+98,429
+5% +$8.81M 0.17% 103
2018
Q4
$164M Buy
1,800,783
+387,961
+27% +$36.3M 0.17% 103
2018
Q3
$139M Sell
1,412,822
-51,552
-4% -$4.77M 0.12% 135
2018
Q2
$125M Sell
1,464,374
-148,417
-9% -$12.4M 0.12% 139
2018
Q1
$129M Buy
1,612,791
+115,031
+8% +$9.49M 0.11% 149
2017
Q4
$121M Buy
1,497,760
+88,482
+6% +$7.09M 0.1% 189
2017
Q3
$110M Buy
1,409,278
+110,756
+9% +$9.2M 0.09% 189
2017
Q2
$115M Buy
1,298,522
+230,832
+22% +$19.5M 0.1% 139
2017
Q1
$86M Buy
1,067,690
+233,995
+28% +$18.3M 0.08% 216
2016
Q4
$59.4M Sell
833,695
-231,616
-22% -$18.2M 0.05% 337
2016
Q3
$92M Buy
1,065,311
+255,997
+32% +$22.3M 0.09% 206
2016
Q2
$70.2M Sell
809,314
-131,061
-14% -$10.6M 0.07% 255
2016
Q1
$70.5M Sell
940,375
-164,136
-15% -$12.4M 0.08% 231
2015
Q4
$85M Buy
1,104,511
+194,948
+21% +$14.7M 0.08% 215
2015
Q3
$60.9M Sell
909,563
-191,937
-17% -$14.1M 0.06% 291
2015
Q2
$81.6M Buy
1,101,500
+1,376
+0.1% +$105K 0.07% 247
2015
Q1
$85.8M Buy
1,100,124
+268,319
+32% +$20.3M 0.08% 229
2014
Q4
$60.1M Sell
831,805
-58,155
-7% -$4.04M 0.05% 345
2014
Q3
$55.1M Buy
889,960
+271,887
+44% +$17.3M 0.05% 358
2014
Q2
$39.4M Sell
618,073
-140,755
-19% -$8.55M 0.04% 442
2014
Q1
$46.7M Buy
758,828
+527
+0.1% +$30.7K 0.05% 353
2013
Q4
$43.5M Buy
758,301
+92,062
+14% +$5.22M 0.04% 421
2013
Q3
$35.5M Sell
666,239
-222,325
-25% -$12M 0.03% 478
2013
Q2
$45.7M Buy
+888,564
New +$43.9M 0.05% 342

Other funds holding MDT

Citigroup's MDT Position: Q2 2026 in Review

Citigroup increased its Medtronic (MDT) stake by 38% in Q2 2026, buying an estimated $41.2M and bringing the position to 1,848,092 shares worth $145M. The position accounts for 0.05% of the portfolio, ranked #345.

Citigroup first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $309M in Q2 2021. 1,806 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Citigroup held 1,848,092 shares of Medtronic worth $145M as of Q2 2026.
  • Citigroup bought 510,181 Medtronic shares in Q2 2026, an estimated $41.2M.
  • Medtronic made up 0.05% of Citigroup's portfolio in Q2 2026, its #345 holding.
  • Citigroup first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Medtronic position peaked at $309M in Q2 2021.
  • 1,806 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.